Home › Deep in - the Cave,' Lilly's CEO Decided Alzheimer's Drug's Fate
 

Keywords :   


Deep in - the Cave,' Lilly's CEO Decided Alzheimer's Drug's Fate

2015-06-26 15:46:47| Agriculture - Topix.net

In an unmarked room in the middle of Eli Lilly & Co.' s Indianapolis campus, researchers holed up for months in 2012 poring over data from the company's failed trials of its experimental Alzheimer's disease treatment, solanezumab, looking for hidden signs the drug had worked.

Tags: deep decided drugs ceo

Category:Agriculture and Forestry

Latest from this category

All news
16.05CFTC charges Agridime and its co-founders with a fraudulent cattle scheme
16.05Baleage: Advantageous for first cutting hay
16.05Tools for environmental challenge
16.05Gov. Reynolds signs Iowa Meat Integrity Bill
16.05Gov. Reynolds signs Iowa Meat Integrity Bill
16.05EU sees significant increase in African swine fever outbreaks in 2023
16.05Study first to characterize microbiota in saliva of weaned piglets in Brazil
15.05Exploring the future of agriculture
Agriculture and Forestry »
17.05Is China's bubble tea bubble about to burst?
17.05Eastern North Pacific Tropical Weather Outlook
17.05Atlantic Tropical Weather Outlook
17.05Business locked in expensive AI 'arms race'
17.05Is the move to electric cars running out of power?
17.05Pornhub partners with UK child abuse fighting charity
16.05CFTC charges Agridime and its co-founders with a fraudulent cattle scheme
16.05Baleage: Advantageous for first cutting hay
More »